Heterogeneity of Lipopolysaccharide as Source of Variability in Bioassays and LPS-Binding Proteins as Remedy
Open accessThe DOI matches its Crossref record; 227 of the 228 references it cites were found in a registry or an index, and 1 are not checked yet.
Abstract
Lipopolysaccharide (LPS), also referred to as endotoxin, is the major component of Gram-negative bacteria’s outer cell wall. It is one of the main types of pathogen-associated molecular patterns (PAMPs) that are known to elicit severe immune reactions in the event of a pathogen trespassing the epithelial barrier and reaching the bloodstream. Associated symptoms include fever and septic shock, which in severe cases, might even lead to death. Thus, the detection of LPS in medical devices and injectable pharmaceuticals is of utmost importance. However, the term LPS does not describe one single molecule but a diverse class of molecules sharing one common feature: their characteristic chemical structure. Each bacterial species has its own pool of LPS molecules varying in their chemical composition and enabling the aggregation into different supramolecular structures upon release from the bacterial cell wall. As this heterogeneity has consequences for bioassays, we aim to examine the great variability of LPS molecules and their potential to form various supramolecular structures. Furthermore, we describe current LPS quantification methods and the LPS-dependent inflammatory pathway and show how LPS heterogeneity can affect them. With the intent of overcoming these challenges and moving towards a universal approach for targeting LPS, we review current studies concerning LPS-specific binders. Finally, we give perspectives for LPS research and the use of LPS-binding molecules.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Figures






Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Notably, bacteria can present diverse variations of the LPS molecule, each with distinct chemical, structural, and functional heterogeneity and varying immunogenicity (Fig. 3e).134”
From Gut dysbiosis in oncology: a risk factor for immunoresistance (2026) · doi:10.1038/s41422-025-01212-6 · cites this paper as [134]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
1 retracted
RETRACTED: Lactosmart: A Novel Therapeutic Molecule for Antimicrobial Defense
Singh, J., Viswanathan, V., Ahmedi, S., Pant, P., Manzoor, N., Singh, T. P., Sharma, P., & Sharma, S. (2021) · Frontiers in Microbiology · doi:10.3389/fmicb.2021.672589 · Cited by 10 · cited 3×
“Origin Binding Molecule LPS Strain (Serotype) LPS Target KD Values Citation Human MD-2 E. coli (O55:B5) Lipid A 3.2 µM [185] Human TLR4 E. coli (O55:B5) Lipid A 14.1 µM [185] Human LBP S.minnesota (Re595) Lipid A 3.5 nM [210] Human rLBP E. coli (J5) Lipid A 1.05 nM [211] Human 5I-histidine-rich polypeptide (Histatin 5…”
BackgroundInfluentialRetractedMeasurement of protein using bicinchoninic acid
Smith, P. K., Krohn, R. I., Hermanson, G. T., Mallia, A. K., Gartner, F. H., Provenzano, M. D., Fujimoto, E. K., Goeke, N. M., Olson, B. J., & Klenk, D. C. (1985) · Analytical Biochemistry · doi:10.1016/0003-2697(85)90442-7 · Cited by 18,482 · cited 1×
“Thus, it is recommended to quantify the protein content in LPS using a protein quantification method, such as the bicinchoninic acid assay [232].”
MethodDefective LPS Signaling in C3H/HeJ and C57BL/10ScCr Mice: Mutations in Tlr4 Gene
Poltorak, A., He, X., Smirnova, I., Liu, M.-Y., Huffel, C. V., Du, X., Birdwell, D., Alejos, E., Silva, M., Galanos, C., et al. (1998) · Science · doi:10.1126/science.282.5396.2085 · Cited by 7,631 · cited 1×
“The most relevant innate immune receptor activated by extracellular LPS is toll–like receptor 4 (TLR4), which was identified in the late 1990s [95,96].”
BackgroundRaetz, C. R. H., & Whitfield, C. (2002) · Annual Review of Biochemistry · doi:10.1146/annurev.biochem.71.110601.135414 · Cited by 4,404 · cited 2×
“KDO is part of the inner core region of LPS and is present in the majority of (G-) bacteria [14].”
BackgroundHoshino, K., Takeuchi, O., Kawai, T., Sanjo, H., Ogawa, T., Takeda, Y., Takeda, K., & Akira, S. (1999) · The Journal of Immunology · doi:10.4049/jimmunol.162.7.3749 · Cited by 3,374
Toll-Like Receptor Signaling Pathways
Kawasaki, T., & Kawai, T. (2014) · Frontiers in Immunology · doi:10.3389/fimmu.2014.00461 · Cited by 3,233 · cited 1×
“TLR4 is mainly expressed on the surface of both immune cells—such as monocytes, macrophages, neutrophils, dendritic cells, and natural killer cells [97,98]—and somatic cells—including fibroblasts and epithelial cells [97,99].”
BackgroundThe structural basis of lipopolysaccharide recognition by the TLR4–MD-2 complex
Park, B. S., Song, D. H., Kim, H. M., Choi, B.-S., Lee, H., & Lee, J.-O. (2009) · Nature · doi:10.1038/nature07830 · Cited by 2,428 · cited 1×
“The loaded MD-2 is then recognized by TLR4 promoting the assembly of a supramolecular TLR4-CD14-MD-2 receptor complex [100,101].”
BackgroundHotchkiss, R. S., Moldawer, L. L., Opal, S. M., Reinhart, K., Turnbull, I. R., & Vincent, J.-L. (2016) · Nature Reviews Disease Primers · doi:10.1038/nrdp.2016.45 · Cited by 1,620
Bacterial endotoxin: molecular relationships of structure to activity and function
Rietschel, E. T., Kirikae, T., Schade, F. U., Mamat, U., Schmidt, G., Loppnow, H., Ulmer, A. J., Zähringer, U., Seydel, U., Di Padova, F., et al. (1994) · The FASEB Journal · doi:10.1096/fasebj.8.2.8119492 · Cited by 1,607 · cited 1×
“5 kDa (R-form) to 70 kDa (S-forms with long O-antigens), being the average between 10 and 20 kDa [5,80,82].”
BackgroundLipid A Modification Systems in Gram-Negative Bacteria
Raetz, C. R. H., Reynolds, C. M., Trent, M. S., & Bishop, R. E. (2007) · Annual Review of Biochemistry · doi:10.1146/annurev.biochem.76.010307.145803 · Cited by 1,340 · cited 1×
“Changing the overall molecular charge by the loss or addition of phosphate groups and/or the addition of positively charged sugar units can influence the resistance against cationic antimicrobial molecules [28,29].”
BackgroundSignal transduction by the lipopolysaccharide receptor, Toll-like receptor-4
Pålsson‐McDermott, E. M., & O'Neill, L. A. J. (2004) · Immunology · doi:10.1111/j.1365-2567.2004.01976.x · Cited by 1,254
TRAM couples endocytosis of Toll-like receptor 4 to the induction of interferon-β
Kagan, J. C., Su, T., Horng, T., Chow, A., Akira, S., & Medzhitov, R. (2008) · Nature Immunology · doi:10.1038/ni1569 · Cited by 1,253
Essential role of MD-2 in LPS responsiveness and TLR4 distribution
Nagai, Y., Akashi, S., Nagafuku, M., Ogata, M., Iwakura, Y., Akira, S., Kitamura, T., Kosugi, A., Kimoto, M., & Miyake, K. (2002) · Nature Immunology · doi:10.1038/ni809 · Cited by 1,020 · cited 1×
“The loaded MD-2 is then recognized by TLR4 promoting the assembly of a supramolecular TLR4-CD14-MD-2 receptor complex [100,101].”
BackgroundSoil microbiomes and one health
Banerjee, S., & van der Heijden, M. G. A. (2023) · Nature Reviews Microbiology · doi:10.1038/s41579-022-00779-w · Cited by 905 · cited 1×
“Bacteria are omnipresent in our environment, in soil, water, and in and on living organisms, such as plants, insects and animals [1].”
BackgroundBinding of polymyxin B to the lipid A portion of bacterial lipopolysaccharides
Morrison, D. C., & Jacobs, D. M. (1976) · Immunochemistry · doi:10.1016/0019-2791(76)90181-6 · Cited by 819 · cited 6×
“Meanwhile, Scott et al. used PMB-functionalized plastic wells to improve endotoxin coating efficiency and develop tests to detect anti-LPS IgG in patients affected by (G-) bacterial infections [161].”
BackgroundMethodInfluentialBacterial Outer Membrane Vesicles Mediate Cytosolic Localization of LPS and Caspase-11 Activation
Vanaja, S. K., Russo, A. J., Behl, B., Banerjee, I., Yankova, M., Deshmukh, S. D., & Rathinam, V. A. K. (2016) · Cell · doi:10.1016/j.cell.2016.04.015 · Cited by 727 · cited 1×
“It has recently become clear that LPS may also access the cytosol via the clathrinmediated endocytosis of outer membrane vesicles (OMVs) [106,107] released from bacteria during growth and intracellular infections [107–109].”
BackgroundLiving at the Extremes: Extremophiles and the Limits of Life in a Planetary Context
Merino, N., Aronson, H. S., Bojanova, D. P., Feyhl-Buska, J., Wong, M. L., Zhang, S., & Giovannelli, D. (2019) · Frontiers in Microbiology · doi:10.3389/fmicb.2019.00780 · Cited by 658
Hirschfeld, M., Weis, J. J., Toshchakov, V., Salkowski, C. A., Cody, M. J., Ward, D. C., Qureshi, N., Michalek, S. M., & Vogel, S. N. (2001) · Infection and Immunity · doi:10.1128/iai.69.3.1477-1482.2001 · Cited by 655 · cited 1×
“Porphyromonas gingivalis 1 (0 + 1) 5 (3 + 2) 15–17 Weak agonist [69]”
Targeting Inflammation Driven by HMGB1
Yang, H., Wang, H., & Andersson, U. (2020) · Frontiers in Immunology · doi:10.3389/fimmu.2020.00484 · Cited by 636 · cited 1×
“Another access pathway might be through the high-mobility group box 1 (HMGB1) protein, which can bind LPS extracellularly and favor its uptake and subsequently its endo-lysosomal escape in conjunction with the receptor for advanced glycation end products (RAGE) [110,111].”
BackgroundOuter Membrane Vesicles (OMVs) of Gram-negative Bacteria: A Perspective Update
Jan, A. T. (2017) · Frontiers in Microbiology · doi:10.3389/fmicb.2017.01053 · Cited by 617
The Endotoxin Delivery Protein HMGB1 Mediates Caspase-11-Dependent Lethality in Sepsis
Deng, M., Tang, Y., Li, W., Wang, X., Zhang, R., Zhang, X., Zhao, X., Liu, J., Tang, C., Liu, Z., et al. (2018) · Immunity · doi:10.1016/j.immuni.2018.08.016 · Cited by 591 · cited 1×
“Another access pathway might be through the high-mobility group box 1 (HMGB1) protein, which can bind LPS extracellularly and favor its uptake and subsequently its endo-lysosomal escape in conjunction with the receptor for advanced glycation end products (RAGE) [110,111].”
BackgroundHuman CAP18: a novel antimicrobial lipopolysaccharide-binding protein
Larrick, J. W., Hirata, M., Balint, R. F., Lee, J., Zhong, J., & Wright, S. C. (1995) · Infection and Immunity · doi:10.1128/iai.63.4.1291-1297.1995 · Cited by 573
TRPA1 channels mediate acute neurogenic inflammation and pain produced by bacterial endotoxins
Meseguer, V., Alpizar, Y. A., Luis, E., Tajada, S., Denlinger, B., Fajardo, O., Manenschijn, J.-A., Fernández-Peña, C., Talavera, A., Kichko, T., et al. (2014) · Nature Communications · doi:10.1038/ncomms4125 · Cited by 479 · cited 2×
“Further LPS-sensing mechanisms and binding molecules have been identified in recent years, including lactoferrin, beta-defensins, and the transient receptor potential cation channel, subfamily A, member 1 (TRPA1) [113], which plays a crucial role in neurogenic inflammation and pain production during infection with (G-…”
BackgroundMethods of endotoxin removal from biological preparations: a review.
Magalhães, P. O., Lopes, A. M., Mazzola, P. G., Rangel‐Yagui, C. D. O., Penna, T. C. V., & Pessoa, A. (2007) · PubMed · Cited by 414
Endotoxin: The uninvited guest
Gorbet, M. B., & Sefton, M. V. (2005) · Biomaterials · doi:10.1016/j.biomaterials.2005.04.063 · Cited by 410 · cited 1×
“5 kDa (R-form) to 70 kDa (S-forms with long O-antigens), being the average between 10 and 20 kDa [5,80,82].”
BackgroundAntibacterial Agents That Inhibit Lipid A Biosynthesis
Onishi, H. R., Pelak, B. A., Gerckens, L. S., Silver, L. L., Kahan, F. M., Chen, M.-H., Patchett, A. A., Galloway, S. M., Hyland, S. A., Anderson, M. S., et al. (1996) · Science · doi:10.1126/science.274.5289.980 · Cited by 410 · cited 1×
“These fatty acids are anchored in the lipid layer of the outer membrane and play a role in the growth and survival of the bacterium [31].”
BackgroundThe structures of Escherichia coli O-polysaccharide antigens
Stenutz, R., Weintraub, A., & Widmalm, G. (2006) · FEMS Microbiology Reviews · doi:10.1111/j.1574-6976.2006.00016.x · Cited by 406 · cited 1×
“Bacteria with only one O-chain repeating unit are referred to as semi-rough (SR) strains [10].”
BackgroundUbiquitylation of lipopolysaccharide by RNF213 during bacterial infection
Otten, E. G., Werner, E., Crespillo-Casado, A., Boyle, K. B., Dharamdasani, V., Pathe, C., Santhanam, B., & Randow, F. (2021) · Nature · doi:10.1038/s41586-021-03566-4 · Cited by 394 · cited 1×
“Salmonella minnesota 2 7 (4 + 3) 12–16 Agonist [74]”
Recent Advances in Lipopolysaccharide Recognition Systems
Mazgaeen, L., & Gurung, P. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21020379 · Cited by 375
Lactoferrin is a lipid A-binding protein
Appelmelk, B. J., An, Y. Q., Geerts, M., Thijs, B. G., de Boer, H. A., MacLaren, D. M., de Graaff, J., & Nuijens, J. H. (1994) · Infection and Immunity · doi:10.1128/iai.62.6.2628-2632.1994 · Cited by 362 · cited 1×
“coli (various serotypes), Pseudomonas aeruginosa, Klebsiella pneumoniae, Neisseria meningitides, Neisseria gonorrhoeae, Haemophilus influenzae, Branhamella catarrhalis, Shigella flexneri, Helicobacter pylori Lipid A 2 nM [213]”
BackgroundLactoferrin down-regulates the LPS-induced cytokine production in monocytic cells via NF-κB
Håversen, L., Ohlsson, B. G., Hahn-Zoric, M., Hanson, L. Å., & Mattsby-Baltzer, I. (2002) · Cellular Immunology · doi:10.1016/s0008-8749(03)00006-6 · Cited by 336
Lipopolysaccharide Binding Protein-mediated Complexation of Lipopolysaccharide with Soluble CD14
Tobias, P. S., Soldau, K., Gegner, J. A., Mintz, D., & Ulevitch, R. J. (1995) · Journal of Biological Chemistry · doi:10.1074/jbc.270.18.10482 · Cited by 324
Biological activities of lipopolysaccharides are determined by the shape of their lipid A portion
Schromm, A. B., Brandenburg, K., Loppnow, H., Moran, A. P., Koch, M. H. J., Rietschel, E. T., & Seydel, U. (2000) · European Journal of Biochemistry · doi:10.1046/j.1432-1327.2000.01204.x · Cited by 319 · cited 2×
“Moreover, in the last 25 years, it has become increasingly clear that in the context of innate immune reactivity, all LPS molecules are not created equal; in fact, modifications to the lipid A chemical structure can dramatically impact the potency of TLR4 activation [12].”
BackgroundEndotoxemia: Methods of detection and clinical correlates
Hurley, J. C. (1995) · Clinical Microbiology Reviews · doi:10.1128/cmr.8.2.268 · Cited by 318
Review: Lipopolysaccharide biosynthesis in Pseudomonas aeruginosa
King, J. D., Kocíncová, D., Westman, E. L., & Lam, J. S. (2009) · Innate Immunity · doi:10.1177/1753425909106436 · Cited by 312
Becker, M. N., Diamond, G., Verghese, M. W., & Randell, S. H. (2000) · Journal of Biological Chemistry · doi:10.1074/jbc.m000184200 · Cited by 308
Iwanaga, S., Kawabata, S.-I., & Muta, T. (1998) · Journal of Biochemistry · doi:10.1093/oxfordjournals.jbchem.a021894 · Cited by 284
Youn, J. H., Oh, Y. J., Kim, E. S., Choi, J. E., & Shin, J.-S. (2008) · The Journal of Immunology · doi:10.4049/jimmunol.180.7.5067 · Cited by 281
Recognition of lipid A variants by the TLR4-MD-2 receptor complex
Maeshima, N., & Fernandez, R. C. (2013) · Frontiers in Cellular and Infection Microbiology · doi:10.3389/fcimb.2013.00003 · Cited by 280
Structure and genetics of Escherichia coli O antigens
Liu, B., Furevi, A., Perepelov, A. V., Guo, X., Cao, H., Wang, Q., Reeves, P. R., Knirel, Y. A., Wang, L., & Widmalm, G. (2020) · FEMS Microbiology Reviews · doi:10.1093/femsre/fuz028 · Cited by 278 · cited 1×
“Due to its uniqueness, the O-antigen serves as a fingerprint to determine bacterial species and serotype [15].”
BackgroundArroyo, L. A., Herrera, C. M., Fernandez, L., Hankins, J. V., Trent, M. S., & Hancock, R. E. W. (2011) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.00256-11 · Cited by 275 · cited 1×
“Acinetobacter baumannii 2 6 (4 + 2) 7 (4 + 3) 12–14 Agonist [46]”
Does the shape of lipid A determine the interaction of LPS with Toll-like receptors?
Netea, M. G., van Deuren, M., Kullberg, B. J., Cavaillon, J.-M., & Van der Meer, J. W. M. (2002) · Trends in Immunology · doi:10.1016/s1471-4906(01)02169-x · Cited by 268
Structural Studies on the Hexose Region of the Core in Lipopolysaccharides from Enterobacteriaceae
JANSSON, P.-E., LINDBERG, B., LINDBERG, A. A., & WOLLIN, R. (2005) · European Journal of Biochemistry · doi:10.1111/j.1432-1033.1981.tb06241.x · Cited by 263 · cited 1×
“The outer core typically comprises the hexoses glucose, galactose, and N- acetylglucosamine, among others [18].”
BackgroundVariation in lipid A structure in the pathogenic yersiniae
Rebeil, R., Ernst, R. K., Gowen, B. B., Miller, S. I., & Hinnebusch, B. J. (2004) · Molecular Microbiology · doi:10.1111/j.1365-2958.2004.04059.x · Cited by 255
Gazzano-Santoro, H., Parent, J. B., Grinna, L., Horwitz, A., Parsons, T., Theofan, G., Elsbach, P., Weiss, J., & Conlon, P. J. (1992) · Infection and Immunity · doi:10.1128/iai.60.11.4754-4761.1992 · Cited by 254
Elass-Rochard, E., Roseanu, A., Legrand, D., Trif, M., Salmon, V, Motas, C., Montreuil, J., & Spik, G. (1995) · Biochemical Journal · doi:10.1042/bj3120839 · Cited by 251 · cited 1×
“5 nM Low-affinity binding site: Human 390 nM [186]”
BackgroundKawahara, K., Tsukano, H., Watanabe, H., Lindner, B., & Matsuura, M. (2002) · Infection and Immunity · doi:10.1128/iai.70.8.4092-4098.2002 · Cited by 246 · cited 2×
“This again highlights the variability and options for the structural changes of lipid A, as these changes cannot only be caused by low or elevated temperatures [41] but also by altering other growth conditions, such as osmolarity [43] or pH [44,45].”
BackgroundIntestinal myofibroblasts in innate immune responses of the intestine
Otte, J.-M., Rosenberg, I. M., & Podolsky, D. K. (2003) · Gastroenterology · doi:10.1016/s0016-5085(03)00403-7 · Cited by 242 · cited 1×
“TLR4 is mainly expressed on the surface of both immune cells—such as monocytes, macrophages, neutrophils, dendritic cells, and natural killer cells [97,98]—and somatic cells—including fibroblasts and epithelial cells [97,99].”
BackgroundZamyatina, A., & Heine, H. (2020) · Frontiers in Immunology · doi:10.3389/fimmu.2020.585146 · Cited by 239 · cited 2×
“Caspases, however, seem to respond to lipid A variants more broadly and with less sensitivity toward structure than does the TLR4 receptor complex [109,125].”
BackgroundDiscovery of new biosynthetic pathways: the lipid A story
Raetz, C. R. H., Guan, Z., Ingram, B. O., Six, D. A., Song, F., Wang, X., & Zhao, J. (2009) · Journal of Lipid Research · doi:10.1194/jlr.r800060-jlr200 · Cited by 232
Mandell, L., Moran, A. P., Cocchiarella, A., Houghton, J., Taylor, N., Fox, J. G., Wang, T. C., & Kurt-Jones, E. A. (2004) · Infection and Immunity · doi:10.1128/iai.72.11.6446-6454.2004 · Cited by 226
Cyanobacterial lipopolysaccharides and human health – a review
Stewart, I., Schluter, P. J., & Shaw, G. R. (2006) · Environmental Health · doi:10.1186/1476-069x-5-7 · Cited by 222
Influence of various dust sampling and extraction methods on the measurement of airborne endotoxin
Douwes, J., Versloot, P., Hollander, A., Heederik, D., & Doekes, G. (1995) · Applied and Environmental Microbiology · doi:10.1128/aem.61.5.1763-1769.1995 · Cited by 207 · cited 2×
“Studies showed that repeated freeze/thaw cycles can elicit a conformational alteration in the phosphate-heptose region [228], which can lead to a loss of its biological potency by 25% after every cycle [229].”
BackgroundSMAP‐29: a potent antibacterial and antifungal peptide from sheep leukocytes
Skerlavaj, B., Benincasa, M., Risso, A., Zanetti, M., & Gennaro, R. (1999) · FEBS Letters · doi:10.1016/s0014-5793(99)01600-2 · Cited by 205 · cited 2×
“Sheep leukocytes Sheep myeloid antimicrobial peptide-29 (SMAP-29) or (SC5) [194]”
BackgroundInfluentialChromogenic Substrates for Horseshoe Crab Clotting Enzyme
Iwanaga, S., Morita, T., Harada, T., Nakamura, S., Niwa, M., Takada, K., Kimura, T., & Sakakibara, S. (1978) · Pathophysiology of Haemostasis and Thrombosis · doi:10.1159/000214260 · Cited by 204
SARTORIUS, C., DUNN, M. F., & ZEPPEZAUER, M. (1988) · European Journal of Biochemistry · doi:10.1111/j.1432-1033.1988.tb14398.x · Cited by 203
The inflammatory cytokine response to Chlamydia trachomatis infection is endotoxin mediated
Ingalls, R. R., Rice, P. A., Qureshi, N., Takayama, K., Lin, J. S., & Golenbock, D. T. (1995) · Infection and Immunity · doi:10.1128/iai.63.8.3125-3130.1995 · Cited by 197 · cited 2×
“, TLR4 receptors), preventing the binding of agonistic LPS variants and inhibiting the downstream inflammatory cascade [127].”
BackgroundDistribution of Core Oligosaccharide Types in Lipopolysaccharides from Escherichia coli
Amor, K., Heinrichs, D. E., Frirdich, E., Ziebell, K., Johnson, R. P., & Whitfield, C. (2000) · Infection and Immunity · doi:10.1128/iai.68.3.1116-1124.2000 · Cited by 192 · cited 1×
“In Escherichia coli, five different core types are known; they share a (hexose)3 carbohydrate backbone and two side chain residues in this backbone [19].”
BackgroundLagrange, B., Benaoudia, S., Wallet, P., Magnotti, F., Provost, A., Michal, F., Martin, A., Di Lorenzo, F., Py, B. F., Molinaro, A., et al. (2018) · Nature Communications · doi:10.1038/s41467-017-02682-y · Cited by 192
Bacterial modification of LPS and resistance to antimicrobial peptides
Gunn, J. S. (2001) · Journal of Endotoxin Research · doi:10.1177/09680519010070011001 · Cited by 191
Brucella spp noncanonical LPS: structure, biosynthesis, and interaction with host immune system
Cardoso, P. G., Macedo, G. C., Azevedo, V., & Oliveira, S. C. (2006) · Microbial Cell Factories · doi:10.1186/1475-2859-5-13 · Cited by 186
Ribi, E., Anacker, R. L., Brown, R., Haskins, W. T., Malmgren, B., Milner, K. C., & Rudbach, J. A. (1966) · Journal of Bacteriology · doi:10.1128/jb.92.5.1493-1509.1966 · Cited by 175
Function and Regulation of Noncanonical Caspase-4/5/11 Inflammasome
Matikainen, S., Nyman, T. A., & Cypryk, W. (2020) · The Journal of Immunology · doi:10.4049/jimmunol.2000373 · Cited by 173 · cited 1×
“Mature GSDMD then migrates to the membrane to form large transmembrane pores that cause cell swelling and lysis, ultimately favoring the release of highly inflammatory intracellular content in the cell surrounding and destroying the replication niche of intracellular bacteria (Figure 3) [112].”
BackgroundSARS-CoV-2 spike protein binds to bacterial lipopolysaccharide and boosts proinflammatory activity
Petruk, G., Puthia, M., Petrlova, J., Samsudin, F., Strömdahl, A.-C., Cerps, S., Uller, L., Kjellström, S., Bond, P. J., & Schmidtchen, A. A. (2021) · Journal of Molecular Cell Biology · doi:10.1093/jmcb/mjaa067 · Cited by 173
Effect of Cold Shock on Lipid A Biosynthesis inEscherichia coli
Carty, S. M., Sreekumar, K. R., & Raetz, C. R. H. (1999) · Journal of Biological Chemistry · doi:10.1074/jbc.274.14.9677 · Cited by 172 · cited 1×
“Escherichia coli (12 ◦C) 2 6 (3 + 3) 12–14 [40]”
Evaluation of Lipopolysaccharide Aggregation by Light Scattering Spectroscopy
Santos, N. C., Silva, A. C., Castanho, M. A. R. B., Martins‐Silva, J., & Saldanha, C. (2003) · ChemBioChem · doi:10.1002/cbic.200390020 · Cited by 165 · cited 1×
“In fact, the determination of CMC is dependent on several physical properties, such as osmotic pressure, turbidity, electrical conductance, and surface tension [81].”
BackgroundWEINTRAUB, A., ZÄHRINGER, U., WOLLENWEBER, H., SEYDEL, U., & RIETSCHEL, E. T. (1989) · European Journal of Biochemistry · doi:10.1111/j.1432-1033.1989.tb14945.x · Cited by 163 · cited 1×
“Bacteroides fragilis 1 (0 + 1) 5 (3 + 2) 15–17 Weak agonist [49]”
Sensitivity of Limulus amebocyte lysate (LAL) to LAL-reactive glucans
Roslansky, P. F., & Novitsky, T. J. (1991) · Journal of Clinical Microbiology · doi:10.1128/jcm.29.11.2477-2483.1991 · Cited by 154
LL-37 Protects Rats against Lethal Sepsis Caused by Gram-Negative Bacteria
Cirioni, O., Giacometti, A., Ghiselli, R., Bergnach, C., Orlando, F., Silvestri, C., Mocchegiani, F., Licci, A., Skerlavaj, B., Rocchi, M., et al. (2006) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.50.5.1672-1679.2006 · Cited by 152
Matsuzaki, K., Sugishita, K.-I., & Miyajima, K. (1999) · FEBS Letters · doi:10.1016/s0014-5793(99)00443-3 · Cited by 151
Untersuchungen über das Choleragift
Pfeiffer, R. (1892) · Zeitschrift für Hygiene und Infektionskrankheiten · doi:10.1007/bf02284303 · Cited by 149
Novel Modification of Lipid A of Francisella tularensis
Phillips, N. J., Schilling, B., McLendon, M. K., Apicella, M. A., & Gibson, B. W. (2004) · Infection and Immunity · doi:10.1128/iai.72.9.5340-5348.2004 · Cited by 144 · cited 1×
“Francisella tularensis 1 (0 + 1) 1 (0 + 1) 4 (2 + 2) 16–18 No agonist and no antagonist [58,59]”
SIDORCZYK, Z., ZÄHRINGER, U., & RIETSCHEL, E. T. (1983) · European Journal of Biochemistry · doi:10.1111/j.1432-1033.1983.tb07789.x · Cited by 141 · cited 1×
“Proteus mirabilis 1 (1 + 0) 2 7 (4 + 3) 14–16 [70]”
Carlsson, A., Nyström, T., de Cock, H., & Bennich, H. (1998) · Microbiology · doi:10.1099/00221287-144-8-2179 · Cited by 141
Lipopolysaccharide O-antigen delays plant innate immune recognition of Xylella fastidiosa
Rapicavoli, J. N., Blanco‐Ulate, B., Muszyński, A., Figueroa-Balderas, R. E., Morales‐Cruz, A., Azadi, P., Dobruchowska, J. M., Castro, C., Cantù, D., & Roper, M. C. (2018) · Nature Communications · doi:10.1038/s41467-018-02861-5 · Cited by 139 · cited 1×
“A similar delaying effect was observed in the innate immune response of plants when attacked by the plant pathogen Xylella fastidiosa [119].”
BackgroundKaca, W., Roth, R. I., & Levin, J. (1994) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(17)31501-6 · Cited by 137
Probing the Penetration of Antimicrobial Polymyxin Lipopeptides into Gram-Negative Bacteria
Deris, Z. Z., Swarbrick, J. D., Roberts, K. D., Azad, M. A. K., Akter, J., Horne, A. S., Nation, R. L., Rogers, K. L., Thompson, P. E., Velkov, T., et al. (2014) · Bioconjugate Chemistry · doi:10.1021/bc500094d · Cited by 137 · cited 3×
“PMB has been used as a positive control for neutralization and binding affinity studies [188–190], and was used as a starting point by Deris et al. in the development of the semi-synthetic probe MIPS-9451 [191].”
BackgroundInfluentialChemical structure of the lipopolysaccharide of Haemophilus influenzae strain I‐69 Rd−/b+
Helander, I. M., Lindner, B., Brade, H., ALTMANN, K., Lindberg, A. A., Rietschel, E. T., & Zähringer, U. (1988) · European Journal of Biochemistry · doi:10.1111/j.1432-1033.1988.tb14397.x · Cited by 136
Bengoechea, J. A., Najdenski, H., & Skurnik, M. (2004) · Molecular Microbiology · doi:10.1111/j.1365-2958.2004.03987.x · Cited by 133 · cited 1×
“It was shown that absence of O-antigen in the outer membrane decreases its stability, and hence increases stress levels for the bacterium [11].”
BackgroundMolecular mechanism of hemolymph clotting system in Limulus
Iwanaga, S., Miyata, T., Tokunaga, F., & Muta, T. (1992) · Thrombosis Research · doi:10.1016/0049-3848(92)90124-s · Cited by 133
Yu, L., Tan, M., Ho, B., Ding, J. L., & Wohland, T. (2005) · Analytica Chimica Acta · doi:10.1016/j.aca.2005.09.008 · Cited by 130
Ernst, R. K., Moskowitz, S. M., Emerson, J. C., Kraig, G. M., Adams, K. N., Harvey, M. D., Ramsey, B., Speert, D. P., Burns, J. L., & Miller, S. I. (2007) · The Journal of Infectious Diseases · doi:10.1086/521367 · Cited by 128 · cited 1×
“This again highlights the variability and options for the structural changes of lipid A, as these changes cannot only be caused by low or elevated temperatures [41] but also by altering other growth conditions, such as osmolarity [43] or pH [44,45].”
BackgroundZähringer, U., Knirel, Y. A., Lindner, B., Helbig, J. H., Sonesson, A., Marre, R., & Rietschel, E. T. (1995) · PubMed · Cited by 122
Gangloff, S. C., Hijiya, N., Haziot, A., & Goyert, S. M. (1999) · Clinical Infectious Diseases · doi:10.1086/515176 · Cited by 122
Gibbons, H. S., Kalb, S. R., Cotter, R. J., & Raetz, C. R. H. (2005) · Molecular Microbiology · doi:10.1111/j.1365-2958.2004.04409.x · Cited by 116 · cited 1×
“This again highlights the variability and options for the structural changes of lipid A, as these changes cannot only be caused by low or elevated temperatures [41] but also by altering other growth conditions, such as osmolarity [43] or pH [44,45].”
BackgroundKim, J., Lee, E., Shin, S., Jeong, K., Jee-Young, L., Bae, S., Kim, S., Lee, J., Kim, S., Lee, D. G., et al. (2011) · Journal of Biological Chemistry · doi:10.1074/jbc.m111.269225 · Cited by 116 · cited 1×
“Among these disciplines, the medical sector can benefit greatly from these advances by using LPS-binding molecules as anti-inflammatory agents [171,172] or tools to remove endotoxin from the blood of sepsis patients [173].”
BackgroundIdentification of a Second Lipopolysaccharide in Porphyromonas gingivalis W50
Rangarajan, M., Aduse-Opoku, J., Paramonov, N., Hashim, A., Bostanci, N., Fraser, O. P., Tarelli, E., & Curtis, M. A. (2008) · Journal of Bacteriology · doi:10.1128/jb.01868-07 · Cited by 111
Lipopolysaccharide Structure and the Phenomenon of Low Endotoxin Recovery
Gorman, A., & Golovanov, A. P. (2022) · European Journal of Pharmaceutics and Biopharmaceutics · doi:10.1016/j.ejpb.2022.10.006 · Cited by 111 · cited 4×
“The limulus’ blood is, in fact, rich in innate immune cells called amebocytes, which are responsible for defending it against pathogens such as (G-) bacteria [122,138].”
BackgroundMethodInfluentialStructural Analysis of the Lipopolysaccharide fromChlamydia trachomatis Serotype L2
Rund, S., Lindner, B., Brade, H., & Holst, O. (1999) · Journal of Biological Chemistry · doi:10.1074/jbc.274.24.16819 · Cited by 110
Lipopolysaccharides: structure, function and bacterial identification
Caroff, M., & Novikov, A. (2020) · OCL · doi:10.1051/ocl/2020025 · Cited by 110
Toll‐Like Receptors in Natural Killer Cells and Their Application for Immunotherapy
Noh, J.-Y., Yoon, S. R., Kim, T., Choi, I., & Jung, H. (2020) · Journal of Immunology Research · doi:10.1155/2020/2045860 · Cited by 109 · cited 1×
“TLR4 is mainly expressed on the surface of both immune cells—such as monocytes, macrophages, neutrophils, dendritic cells, and natural killer cells [97,98]—and somatic cells—including fibroblasts and epithelial cells [97,99].”
BackgroundTan, N. S., Ng, M. L. P., Yau, Y. H., Chong, P. K. W., Ho, B., & Ding, J. L. (2000) · The FASEB Journal · doi:10.1096/fj.99-0866com · Cited by 107
Cullen, T. W., & Trent, M. S. (2010) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0913451107 · Cited by 107
Di Lorenzo, F., Pither, M. D., Martufi, M., Scarinci, I., Guzmán-Caldentey, J., Łakomiec, E., Jachymek, W., Bruijns, S. C. M., Santamaría, S. M., Frick, J.-S., et al. (2020) · ACS Central Science · doi:10.1021/acscentsci.0c00791 · Cited by 101 · cited 2×
“Bacteroides vulgatus 1 (0 + 1) 5 (3 + 2) 15–17 Weak agonist [50]”
BackgroundKushibiki, T., Kamiya, M., Aizawa, T., Kumaki, Y., Kikukawa, T., Mizuguchi, M., Demura, M., Kawabata, S.-I., & Kawano, K. (2014) · Biochimica et Biophysica Acta (BBA) - Proteins and Proteomics · doi:10.1016/j.bbapap.2013.12.017 · Cited by 98 · cited 1×
“Horseshoe crab Tachyplesin I (TP I) Phosphate groups and KDO under 100 μM [204]”
BackgroundMD-2-mediated Ionic Interactions between Lipid A and TLR4 Are Essential for Receptor Activation
Meng, J., Lien, E., & Golenbock, D. T. (2010) · Journal of Biological Chemistry · doi:10.1074/jbc.m109.075127 · Cited by 96
Biological Activity of Masked Endotoxin
Schwarz, H., Gornicec, J., Neuper, T., Parigiani, M. A., Wallner, M., Duschl, A., & Horejs-Hoeck, J. (2017) · Scientific Reports · doi:10.1038/srep44750 · Cited by 96
Structure–activity relationships of fowlicidin‐1, a cathelicidin antimicrobial peptide in chicken
Xiao, Y., Dai, H., Bommineni, Y. R., Soulages, J. L., Gong, Y., Prakash, O., & Zhang, G. (2006) · FEBS Journal · doi:10.1111/j.1742-4658.2006.05261.x · Cited by 92
A serine protease zymogen functions as a pattern-recognition receptor for lipopolysaccharides
Ariki, S., Koori, K., Osaki, T., Motoyama, K., Inamori, K., & Kawabata, S.-I. (2004) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0306904101 · Cited by 90
Saving the horseshoe crab: A synthetic alternative to horseshoe crab blood for endotoxin detection
Maloney, T., Phelan, R., & Simmons, N. (2018) · PLOS Biology · doi:10.1371/journal.pbio.2006607 · Cited by 89 · cited 1×
“LPS is then detected using a recombinantly produced factor C, which then processes a substrate to generate a machine-quantifiable fluorescent signal (Figure 5) [153,155,156].”
MethodKinetics of Binding of LPS to Recombinant CD14, TLR4, and MD-2 Proteins
Shin, H. J., Lee, H., Park, J. D., Hyun, H. C., Sohn, H. O., Lee, D. W., & Kim, Y. S. (2007) · Molecules and Cells · doi:10.1016/s1016-8478(23)10763-1 · Cited by 87
Structural analysis of the nontoxic lipid A of Rhodobacter capsulatus 37b4
KRAUSS, J. H., SEYDEL, U., WECKESSER, J., & MAYER, H. (1989) · European Journal of Biochemistry · doi:10.1111/j.1432-1033.1989.tb14677.x · Cited by 87 · cited 2×
“Antagonistic LPS variants do not activate the immune system and can even block LPS-binding sites (e.g., TLR4 receptors), preventing the binding of agonistic LPS variants and inhibiting the downstream inflammatory cascade [127].”
Youn, J. H., Kwak, M. S., Wu, J., Kim, E. S., Ji, Y., Min, H. J., Yoo, J., Choi, J. E., Cho, H., & Shin, J. (2011) · European Journal of Immunology · doi:10.1002/eji.201141391 · Cited by 86
Lukáčová, M., Barák, I., & Kazár, J. (2007) · Clinical Microbiology and Infection · doi:10.1111/j.1469-0691.2007.01876.x · Cited by 84 · cited 1×
“This transition is, most of the time, irreversible [16].”
BackgroundCharacterization of a Novel Lipid A Containingd-Galacturonic Acid That Replaces Phosphate Residues
Plötz, B. M., Lindner, B., STETTER, K. O., & Holst, O. (2000) · Journal of Biological Chemistry · doi:10.1074/jbc.275.15.11222 · Cited by 82 · cited 3×
“The hydrophobic acyl chains of lipid A are commonly bound to the GlcN by two ester and two amide bondings, while some species form only amide bondings [23,30].”
BackgroundInfluentialTrautmann, M., Held, T. K., Šuša, M., Karajan, M. A., Wulf, A., Cross, A. S., & Marre, R. (1998) · Clinical & Experimental Immunology · doi:10.1046/j.1365-2249.1998.00445.x · Cited by 81 · cited 1×
“Additionally, the use of anti-O-antigen mAbs as capture/detection proteins is prone to cross-reactivity, and their production is often laborious and expensive since many LPS variants have not yet been isolated [9,162].”
BackgroundScott, A. J., Oyler, B. L., Goodlett, D. R., & Ernst, R. K. (2017) · Biochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids · doi:10.1016/j.bbalip.2017.01.004 · Cited by 81
The Vibrio cholerae VprA-VprB Two-Component System Controls Virulence through Endotoxin Modification
Herrera, C. M., Crofts, A. A., Henderson, J. C., Pingali, S. C., Davies, B. W., & Trent, M. S. (2014) · mBio · doi:10.1128/mbio.02283-14 · Cited by 80
Structural and thermodynamic analyses of the interaction between melittin and lipopolysaccharide
Bhunia, A., Domadia, P. N., & Bhattacharjya, S. (2007) · Biochimica et Biophysica Acta (BBA) - Biomembranes · doi:10.1016/j.bbamem.2007.07.017 · Cited by 75
Aggregation behavior and size of lipopolysaccharide from Escherichia coli O55:B5
Bergstrand, A., Svanberg, C., Langton, M., & Nydén, M. (2006) · Colloids and Surfaces B Biointerfaces · doi:10.1016/j.colsurfb.2006.06.007 · Cited by 75 · cited 3×
“Here, the CMC, size and shape of aggregates differ mainly depending on the chemical structure of LPS, pH, temperature, amount and type of ions in solution and presence of surfactants, proteins or other molecules [80,83,84].”
BackgroundPerturbation of Lipopolysaccharide (LPS) Micelles by Sushi 3 (S3) Antimicrobial Peptide
Li, P., Wohland, T., Ho, B., & Ding, J. L. (2004) · Journal of Biological Chemistry · doi:10.1074/jbc.m405606200 · Cited by 74
Limulus amebocyte lysate (LAL) detection of endotoxin in human blood
Novitsky, T. J. (1994) · Journal of Endotoxin Research · doi:10.1177/096805199400100407 · Cited by 74
Duerr, C. U., Zenk, S. F., Chassin, C., Pott, J., Gütle, D., Hensel, M., & Hornef, M. W. (2009) · PLoS Pathogens · doi:10.1371/journal.ppat.1000567 · Cited by 72 · cited 1×
“found that wild-type Salmonella strains with an intact O-antigen delayed TLR4-mediated immune activation compared to isogenic O-antigen-lacking mutants in the gut, facilitating bacterial survival and proliferation in the host [118].”
BackgroundYu, H., Dong, J., Gu, Y., Liu, H., Xin, A., Shi, H., Sun, F., Zhang, Y., Lin, D., & Diao, H. (2013) · Journal of Biological Chemistry · doi:10.1074/jbc.m112.411884 · Cited by 71
Comparative Toll-Like Receptor 4-Mediated Innate Host Defense toBordetellaInfection
Mann, P. B., Wolfe, D., Latz, E., Golenbock, D. T., Preston, A., & Harvill, E. T. (2005) · Infection and Immunity · doi:10.1128/iai.73.12.8144-8152.2005 · Cited by 71 · cited 1×
“, lipid A from Alcaligenes faecalis, Bacteroides vulgatus, and Bordetella parapertussis) [48,50,121].”
BackgroundMasking of endotoxin in surfactant samples: Effects on Limulus-based detection systems
Reich, J., Lang, P., Grallert, H., & Motschmann, H. R. (2016) · Biologicals · doi:10.1016/j.biologicals.2016.04.012 · Cited by 71 · cited 2×
“Those factors can separate LPS from micellar into a less active monomeric form [148,150,167], or even interact directly with LPS, reducing its activity and solubility [122,170].”
BackgroundKoshiba, T., Hashii, T., & Kawabata, S.-I. (2006) · Journal of Biological Chemistry · doi:10.1074/jbc.m609198200 · Cited by 68
Structural Regions of MD-2 That Determine the Agonist-Antagonist Activity of Lipid IVa
Muroi, M., & Tanamoto, K. (2006) · Journal of Biological Chemistry · doi:10.1074/jbc.m509193200 · Cited by 67 · cited 1×
“This phenomenon was observed for the LPS precursor lipid IVa, which activated mouse macrophages but acted as an antagonist for human macrophages [130].”
BackgroundScott, B. B., & Barclay, G. R. (1987) · Vox Sanguinis · doi:10.1111/j.1423-0410.1987.tb04893.x · Cited by 67 · cited 1×
“used PMB-functionalized plastic wells to improve endotoxin coating efficiency and develop tests to detect anti-LPS IgG in patients affected by (G-) bacterial infections [161].”
MethodPapadiamantis, A., Klaessig, F., Exner, T., Hofer, S., Hofstaetter, N., Himly, M., Williams, M. A., Doganis, P., Hoover, M. D., Afantitis, A., et al. (2020) · Nanomaterials · doi:10.3390/nano10102033 · Cited by 67
Self-citationPetsch, D., Deckwer, W. ‐., & Anspach, F. B. (1998) · Analytical Biochemistry · doi:10.1006/abio.1998.2655 · Cited by 66 · cited 1×
“These factors relate to both the sample and the buffers used during sample preparation or analysis [90,91,148,150,151,154,166,168,169].”
BackgroundBarker, J. H., Weiss, J. P., Apicella, M. A., & Nauseef, W. M. (2006) · Infection and Immunity · doi:10.1128/iai.02011-05 · Cited by 65 · cited 1×
“Francisella tularensis 1 (0 + 1) 1 (0 + 1) 4 (2 + 2) 16–18 No agonist and no antagonist [58,59]”
Biophysical characterisation of lysozyme binding to LPS Re and lipid A
Brandenburg, K., Koch, M. H. J., & Seydel, U. (1998) · European Journal of Biochemistry · doi:10.1046/j.1432-1327.1998.2580686.x · Cited by 61 · cited 2×
“A decisive factor for this choice is the heterogeneity of LPS since the molecules’ binding affinity differs between bacterial species due to the diversified interdependency of electrostatic and/or amphipathic interactions [177,178].”
Backgroundde Haas, C. J. C., van der Tol, M. E., van Kessel, K. P. M., Verhoef, J., & van Strijp, J. A. G. (1998) · The Journal of Immunology · doi:10.4049/jimmunol.161.7.3607 · Cited by 60
Comparison of Blocking Agents for an Elisa for Lps
Péterfi, Z., & Kocsis, B. (2000) · Journal of Immunoassay · doi:10.1080/01971520009349541 · Cited by 57 · cited 7×
“In this test, similar to a conventional enzyme-linked immunosorbent assay (ELISA), samples are added to plastic wells coated with a bacteriophage-derived receptor protein, which can capture LPS via its core region [153].”
BackgroundInfluentialChemical Structure of Lipid A. The Primary Immunomodulatory Center of Bacterial Lipopolysaccharides.
Alexander, C., & Zähringer, U. (2002) · Trends in Glycoscience and Glycotechnology · doi:10.4052/tigg.14.69 · Cited by 57 · cited 1×
“enterica [36], as elaborated further in Chapter 3.”
BackgroundShimoyama, A., Lorenzo, F. D., Yamaura, H., Mizote, K., Palmigiano, A., Pither, M. D., Speciale, I., Uto, T., Masui, S., Sturiale, L., et al. (2021) · Angewandte Chemie International Edition · doi:10.1002/anie.202012374 · Cited by 56 · cited 2×
“Alcaligenes faecalis 2 6 (3 + 3) 10–14 Weak agonist [48]”
BackgroundCharacterization of the lipopolysaccharide of Moraxella catarrhalis
Masoud, H., Perry, M. B., & Richards, J. C. (1994) · European Journal of Biochemistry · doi:10.1111/j.1432-1033.1994.tb18616.x · Cited by 55 · cited 1×
“Moraxella catarrhalis 3 (1 + 2) 7 (3 + 4) 10–12 Agonist [21,67]”
Masoud, H., Weintraub, S. T., Wang, R., Cotter, R. J., & Holt, S. C. (1991) · European Journal of Biochemistry · doi:10.1111/j.1432-1033.1991.tb16244.x · Cited by 55 · cited 1×
“Actinobacillus actinomycetemcomitans 2 6 (4 + 2) 14 Agonist [47]”
Malgorzata-Miller, G., Heinbockel, L., Brandenburg, K., van der Meer, J. W. M., Netea, M. G., & Joosten, L. A. B. (2016) · Scientific Reports · doi:10.1038/srep34221 · Cited by 55 · cited 3×
“Antagonistic LPS variants do not activate the immune system and can even block LPS-binding sites (e.g., TLR4 receptors), preventing the binding of agonistic LPS variants and inhibiting the downstream inflammatory cascade [127].”
BackgroundLysozyme's lectin-like characteristics facilitates its immune defense function
Zhang, R., Wu, L., Eckert, T., Burg‐Roderfeld, M., Rojas‐Macias, M. A., Lütteke, T., Krylov, V. B., Argunov, D. A., Datta, A., Markart, P., et al. (2017) · Quarterly Reviews of Biophysics · doi:10.1017/s0033583517000075 · Cited by 54
ATR-FTIR study of lipopolysaccharides at mineral surfaces
Parikh, S. J., & Chorover, J. (2007) · Colloids and Surfaces B Biointerfaces · doi:10.1016/j.colsurfb.2007.10.002 · Cited by 53 · cited 1×
“Here, the CMC, size and shape of aggregates differ mainly depending on the chemical structure of LPS, pH, temperature, amount and type of ions in solution and presence of surfactants, proteins or other molecules [80,83,84].”
BackgroundHardie, E. M., & Kruse-Elliott, K. T. (1990) · Journal of Veterinary Internal Medicine · doi:10.1111/j.1939-1676.1990.tb03119.x · Cited by 50
Yibin, G., Zheng, J., Zhou, H., Gengfa, L., Liangxi, W., Guo, W., & Lu, Y. (2005) · Biochemical Pharmacology · doi:10.1016/j.bcp.2005.04.040 · Cited by 49 · cited 4×
“Here, morphological changes of the cell wall were observed after 15 min of incubation with MP-1 [196].”
BackgroundMethodInfluentialInfrared spectroscopy studies of cation effects on lipopolysaccharides in aqueous solution
Parikh, S. J., & Chorover, J. (2006) · Colloids and Surfaces B Biointerfaces · doi:10.1016/j.colsurfb.2006.12.014 · Cited by 49
Pupo, E., Lindner, B., Brade, H., & Schromm, A. B. (2012) · FEBS Journal · doi:10.1111/febs.12104 · Cited by 49 · cited 1×
“By checking their biological activity, they found that rough types dominated the activation of human macrophages when compared to smooth types [17].”
BackgroundZheng, J., Zhou, H., Guo, W., Xiaoyun, G., Gengfa, L., Lu, Y., & Guangxia, X. (2004) · International Immunopharmacology · doi:10.1016/j.intimp.2004.02.004 · Cited by 49
Andres, D., Baxa, U., Hanke‐Gogokhia, C., Seckler, R., & Barbirz, S. (2010) · Biochemical Society Transactions · doi:10.1042/bst0381386 · Cited by 48
Bourassa, D. V., Kannenberg, E. L., Sherrier, D. J., Buhr, R. J., & Carlson, R. W. (2017) · Molecular Plant-Microbe Interactions · doi:10.1094/mpmi-11-16-0230-r · Cited by 48 · cited 1×
“Rhizobium leguminosarum 1 (1 + 0) 0 5 (3 + 2) 14–28 [25]”
SnapShot: Microbial Extremophiles
Schmid, A., Allers, T., & DiRuggiero, J. (2020) · Cell · doi:10.1016/j.cell.2020.01.018 · Cited by 47
Immunomodulatory Effects of Yersinia pestis Lipopolysaccharides on Human Macrophages
Matsuura, M., Takahashi, H., Watanabe, H., Saito, S., & Kawahara, K. (2009) · Clinical and Vaccine Immunology · doi:10.1128/cvi.00336-09 · Cited by 45
Interactions of polymyxin B with lipopolysaccharide-containing membranes
Goode, A., Yeh, V., & Bonev, B. B. (2021) · Faraday Discussions · doi:10.1039/d1fd00036e · Cited by 45 · cited 6×
“Meanwhile, Scott et al. used PMB-functionalized plastic wells to improve endotoxin coating efficiency and develop tests to detect anti-LPS IgG in patients affected by (G-) bacterial infections [161].”
BackgroundMethodInfluentialEndotoxin·albumin complexes transfer endotoxin monomers to MD-2 resulting in activation of TLR4
Esparza, G. A., Teghanemt, A., Zhang, D., Gioannini, T. L., & Weiss, J. P. (2011) · Innate Immunity · doi:10.1177/1753425911422723 · Cited by 44 · cited 1×
“Mostly, BSA is used as a standard protein for this purpose; however, it is known that BSA can interact with LPS [93].”
Backgroundde Haas, C. J. C., Haas, P., van Kessel, K. P. M., & van Strijp, J. A. G. (1998) · Biochemical and Biophysical Research Communications · doi:10.1006/bbrc.1998.9675 · Cited by 42
The Lipid A from Vibrio fischeri Lipopolysaccharide
Phillips, N. J., Adin, D. M., Stabb, E. V., McFall‐Ngai, M., Apicella, M. A., & Gibson, B. W. (2011) · Journal of Biological Chemistry · doi:10.1074/jbc.m111.239475 · Cited by 42 · cited 2×
“Besides additional keto or hydroxyl groups or unsaturated carbon bonds in the center of the chain [32,33], branching and terminal hydroxyl groups [34] are occasionally seen.”
BackgroundKrishnan, M., Choi, J., Jang, A., Choi, S., Yeon, J., Jang, M., Lee, Y., Son, K., Shin, S. Y., Jeong, M. S., et al. (2022) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.2115669119 · Cited by 42
Wu, J., Mu, L., Zhuang, L., Han, Y., Liu, T., Li, J., Yang, Y., Yang, H., & Wei, L. (2015) · Parasites & Vectors · doi:10.1186/s13071-015-1176-8 · Cited by 41 · cited 1×
“Besides influences on cytokine levels, the binding molecule Cecropin-like antimicrobial peptide (SibaCec) showed a dose-dependent reduction in LPS-induced NO and nitrite production in mouse macrophages [224].”
BackgroundRemodeling of Helicobacter pylori lipopolysaccharide
Tran, A. X., Stead, C. M., & Trent, M. S. (2005) · Journal of Endotoxin Research · doi:10.1177/09680519050110030401 · Cited by 40 · cited 1×
“Helicobacter pylori Minor 2 Major 1 (0 + 1) Minor 6 (4 + 2) Major 4 (2 + 2) Minor 12–18 Major 16–18 Major antagonist [63]”
Lorenzo, F. D., Palmigiano, A., Paciello, I., Pallach, M., Garozzo, D., Bernardini, M. L., Cono, V. L., Yakimov, M. M., Molinaro, A., & Silipo, A. (2017) · Marine Drugs · doi:10.3390/md15070201 · Cited by 40 · cited 3×
“Antagonistic LPS variants do not activate the immune system and can even block LPS-binding sites (e.g., TLR4 receptors), preventing the binding of agonistic LPS variants and inhibiting the downstream inflammatory cascade [127].”
BackgroundRestoration of Endotoxin Activity following Alteration by Plasma
Rudbach, J. A., & Johnson, A. G. (1964) · Nature · doi:10.1038/202811a0 · Cited by 39 · cited 1×
“Those factors can separate LPS from micellar into a less active monomeric form [148,150,167], or even interact directly with LPS, reducing its activity and solubility [122,170].”
BackgroundLorenzo, F. D., Billod, J., Martín‐Santamaría, S., Silipo, A., & Molinaro, A. (2017) · European Journal of Organic Chemistry · doi:10.1002/ejoc.201700113 · Cited by 39 · cited 1×
“As antagonistic LPS molecules have the potential to limit endotoxin-induced inflammatory symptoms, they are of great interest for the pharmaceutical field, and have been receiving attention for therapeutic applications [3].”
BackgroundThakur, M., & Dan, A. (2021) · ACS Applied Bio Materials · doi:10.1021/acsabm.1c00006 · Cited by 39
Synthetic Peptides That Mimic The Binding Site Of Horseshoe Crab Antilipopolysaccharide Factor
Kloczewiak, M. A., Black, K. M., Loiselle, P. M., Cavaillon, J., Wainwright, N., & Warren, H. S. (1994) · The Journal of Infectious Diseases · doi:10.1093/infdis/170.6.1490 · Cited by 38
Komaniecka, I., Choma, A., Lindner, B., & Holst, O. (2010) · Chemistry – A European Journal · doi:10.1002/chem.200902390 · Cited by 38 · cited 1×
“Bradyrhizobium elkanii 3 (2 + 1) 0 6 (4 + 2) 12–28 Weak agonist/ antagonist [24]”
Michelini, S., Barbero, F., Prinelli, A., Steiner, P., Weiss, R., Verwanger, T., Andosch, A., Lütz‐Meindl, U., Puntes, V., Drobne, D., et al. (2021) · Nanoscale · doi:10.1039/d0nr09153g · Cited by 38
Self-citationEndoLISA®: a novel and reliable method for endotoxin detection
Grallert, H., Leopoldseder, S., Schütt, M., Kurze, P., & Buchberger, B. (2011) · Nature Methods · doi:10.1038/nmeth.f.350 · Cited by 37
Neutralization of Endotoxin In Vitro and In Vivo by BAC7(1-35), a Proline-Rich Antibacterial Peptide
Ghiselli, R., Giacometti, A., Cirioni, O., Circo, R., Mocchegiani, F., Skerlavaj, B., D’Amato, G., Scalise, G., Zanetti, M., & Saba, V. (2003) · Shock · doi:10.1097/01.shk.0000055236.26446.c9 · Cited by 37
Adwani, S. A., Wallin, C., Balhuizen, M. D., Veldhuizen, E. J. A., Coorens, M., Landreh, M., Végvári, Á., Smith, M. E., Qvarfordt, I., Lindén, A., et al. (2020) · Scientific Reports · doi:10.1038/s41598-020-59071-7 · Cited by 37
Extracorporeal Removal of Endotoxin: The Polymyxin B-Immobilized Fiber Cartridge
Tani, T., Shoji, H., Guadagni, G., & Perego, A. F. (2010) · Contributions to nephrology · doi:10.1159/000315917 · Cited by 36 · cited 1×
“Among these disciplines, the medical sector can benefit greatly from these advances by using LPS-binding molecules as anti-inflammatory agents [171,172] or tools to remove endotoxin from the blood of sepsis patients [173].”
BackgroundLow Endotoxin Recovery—Masking of Naturally Occurring Endotoxin
Reich, J., Weyer, F., Tamura, H., Nagaoka, I., & Motschmann, H. R. (2019) · International Journal of Molecular Sciences · doi:10.3390/ijms20040838 · Cited by 36
Jarvis, B. W., Lichenstein, H. S., & Qureshi, N. (1997) · Infection and Immunity · doi:10.1128/iai.65.8.3011-3016.1997 · Cited by 35
Detecting lipopolysaccharide in the cytosol of mammalian cells: Lessons from MD-2/TLR4
Barker, J. H., & Weiss, J. P. (2019) · Journal of Leukocyte Biology · doi:10.1002/jlb.3mir1118-434r · Cited by 34 · cited 1×
“It has recently become clear that LPS may also access the cytosol via the clathrinmediated endocytosis of outer membrane vesicles (OMVs) [106,107] released from bacteria during growth and intracellular infections [107–109].”
BackgroundChandler, C. E., Harberts, E. M., Pelletier, M. R., Thaipisuttikul, I., Jones, J. W., Hajjar, A. M., Sahl, J. W., Goodlett, D. R., Pride, A. C., Rasko, D. A., et al. (2020) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1917504117 · Cited by 34 · cited 1×
“Yersinia pestis 2 25–27 ◦C: 6 (4 + 2) 37 ◦C: 4 (2 + 2) 12–16 14 Agonist No agonist [41,79]”
KRASIKOVA, I. N., Kapustina, N. V., Isakov, V. V., Dmitrenok, A. S., Dmitrenok, P. S., Gorshkova, N. M., & Федоровна, С. Т. (2004) · European Journal of Biochemistry · doi:10.1111/j.1432-1033.2004.04212.x · Cited by 33 · cited 1×
“Marinomonas vaga 1 (0 + 1) 5 (2 + 3) 10–12 Weak agonist [66]”
Hong, L., Gontsarik, M., Amenitsch, H. W., & Salentinig, S. (2021) · Small · doi:10.1002/smll.202104211 · Cited by 33 · cited 3×
“Furthermore, the supramolecular structures of LPS can be altered by intermolecular interactions [88,90].”
BackgroundInfluentialLin, M., Pan, C., Hui, C., Chen, J., & Wu, J.-L. (2012) · Peptides · doi:10.1016/j.peptides.2012.11.010 · Cited by 32
Human beta-defensin DEFB126 is capable of inhibiting LPS-mediated inflammation
Liu, H., Yu, H., Gu, Y., Xin, A., Zhang, Y., Diao, H., & Lin, D. (2012) · Applied Microbiology and Biotechnology · doi:10.1007/s00253-012-4588-9 · Cited by 31 · cited 2×
“7 macrophages [209], and HeLa cells [172].”
BackgroundMolecular Characterization of Lipopolysaccharide Binding to Humanα-1-Acid Glycoprotein
Huang, J. X., Azad, M. A. K., Yuriev, E., Baker, M. A., Nation, R. L., Li, J., Cooper, M. A., & Velkov, T. (2012) · Journal of Lipids · doi:10.1155/2012/475153 · Cited by 30 · cited 1×
“Pseudomonas aeruginosa 2 6 (3 + 3) 10–12 [71]”
Highly sensitive pyrogen detection on medical devices by the monocyte activation test
Stang, K., Fennrich, S., Krajewski, S., Stoppelkamp, S., Burgener, I. A., Wendel, H.-P., & Post, M. (2014) · Journal of Materials Science Materials in Medicine · doi:10.1007/s10856-013-5136-6 · Cited by 30 · cited 2×
“It can only detect LPS in liquid samples [157] and it is still affected by the presence of chelating agents similar to a conventional LAL assay [90,153,154].”
BackgroundMethodDetection Methods for Lipopolysaccharides: Past and Present
Stromberg, L. R., Mendez, H. M., & Mukundan, H. (2017) · InTech eBooks · doi:10.5772/intechopen.68311 · Cited by 30 · cited 10×
“Meanwhile, Scott et al. used PMB-functionalized plastic wells to improve endotoxin coating efficiency and develop tests to detect anti-LPS IgG in patients affected by (G-) bacterial infections [161].”
BackgroundMethodInfluentialHassan, F., Ren, D., Zhang, W., Merkel, T. J., & Gu, X. (2012) · PLoS ONE · doi:10.1371/journal.pone.0037610 · Cited by 29 · cited 1×
“Moraxella catarrhalis 3 (1 + 2) 7 (3 + 4) 10–12 Agonist [21,67]”
Enthalpic Barriers to the Hydrophobic Binding of Oligosaccharides to Phage P22 Tailspike Protein
Baxa, U., Cooper, A., Weintraub, A., Pfeil, W., & Seckler, R. (2001) · Biochemistry · doi:10.1021/bi0020426 · Cited by 29
Borton, L., & Coleman, K. P. (2018) · ALTEX · doi:10.14573/altex.1709221 · Cited by 29 · cited 1×
“In reporter gene assays, cells are transfected with plasmids containing the TLR4 receptor complex and a reporter gene (NF-κB-luciferase or NF-κB-SEAP) instead, which produces a luminescence signal or a colorimetric reaction upon LPS recognition by TLR4 [90,163] (Figure 5).”
Aggregatibacter actinomycetemcomitans LPS binds human interleukin-8
Ahlstrand, T., Kovesjoki, L., Maula, T., Oscarsson, J., & Ihalin, R. (2018) · Journal of Oral Microbiology · doi:10.1080/20002297.2018.1549931 · Cited by 29
Bello, G., Eriksson, J., Terry, A. E., Edwards, K., Lawrence, M. J., Barlow, D. J., & Harvey, R. D. (2014) · Langmuir · doi:10.1021/la503267k · Cited by 28 · cited 1×
“The authors also tested (R) strains, which presented irregular lamellae or sheet-like structures coexisting with toroids [87,94].”
BackgroundSchwartzman, J. A., Lynch, J. B., Ramos, S. F., Zhou, L. H., Apicella, M. A., Yew, J. Y., & Ruby, E. G. (2019) · Molecular Microbiology · doi:10.1111/mmi.14365 · Cited by 28 · cited 1×
“This again highlights the variability and options for the structural changes of lipid A, as these changes cannot only be caused by low or elevated temperatures [41] but also by altering other growth conditions, such as osmolarity [43] or pH [44,45].”
BackgroundDetecting endotoxin with a flow cytometry-based magnetic aptasensor
Zuo, M.-Y., Chen, L., Jiang, H., Tan, L., Luo, Z., & Wang, Y. (2014) · Analytical Biochemistry · doi:10.1016/j.ab.2014.08.018 · Cited by 26
Bello, G., Bodin, A., Lawrence, M. J., Barlow, D. J., Mason, A. J., Barker, R. D., & Harvey, R. D. (2015) · Biochimica et Biophysica Acta (BBA) - Biomembranes · doi:10.1016/j.bbamem.2015.11.007 · Cited by 26 · cited 1×
“The authors also tested (R) strains, which presented irregular lamellae or sheet-like structures coexisting with toroids [87,94].”
BackgroundUnderstanding lipopolysaccharide aggregation and its influence on activation of Factor C
Wang, C., Nelson, T., Chen, D., Ellis, J. C., & Abbott, N. L. (2019) · Journal of Colloid and Interface Science · doi:10.1016/j.jcis.2019.05.013 · Cited by 26
Ren, J., Gu, J., Gao, H.-F., Xia, P., & Xiao, G. (2008) · International Immunopharmacology · doi:10.1016/j.intimp.2008.01.015 · Cited by 25 · cited 1×
“A decrease in proinflammatory cytokines was observed, including the cytokines TNF-α, IL-1β, and IL-6 both in vitro [206,209,223] and in vivo [206].”
BackgroundNagaoka, I., Yomogida, S., Tamura, H., & Hirata, M. (2004) · Inflammation Research · doi:10.1007/s00011-004-1300-2 · Cited by 25 · cited 2×
“A decrease in proinflammatory cytokines was observed, including the cytokines TNF-α, IL-1β, and IL-6 both in vitro [206,209,223] and in vivo [206].”
BackgroundMethodBinding of a histidine-rich peptide to Porphyromonas gingivalis
MURAKAMI, Y., Shizukuishi, S., Tsunemitsu, A., Nakashima, K., Kato, Y., & Aimoto, S. (1991) · FEMS Microbiology Letters · doi:10.1111/j.1574-6968.1991.tb04890.x · Cited by 25
Correa, W., Brandenburg, K., Zähringer, U., Kishore, R. S. K., Khan, T. A., & von Wintzingerode, F. (2017) · International Journal of Molecular Sciences · doi:10.3390/ijms18122737 · Cited by 25 · cited 1×
“These factors relate to both the sample and the buffers used during sample preparation or analysis [90,91,148,150,151,154,166,168,169].”
BackgroundGarcía-Vello, P., Lorenzo, F. D., Lamprinaki, D., Notaro, A., Speciale, I., Molinaro, A., Juge, N., & Castro, C. D. (2020) · ChemBioChem · doi:10.1002/cbic.202000751 · Cited by 25 · cited 1×
“Fusobacterium nucleatum 2 6 (4 + 2) 14–16 Agonist [60]”
Arenas, J., Pupo, E., Phielix, C., David, D., Zariri, A., Zamyatina, A., Tommassen, J., & van der Ley, P. (2020) · Vaccines · doi:10.3390/vaccines8040594 · Cited by 24 · cited 1×
“Recent experiments have found that the acyl chain length in particular is a key component that determines the overall potency of immune response following LPS detection [126].”
BackgroundKobayashi, Y., Takahashi, T., Shibata, T., Ikeda, S., Koshiba, T., Mizumura, H., Oda, T., & Kawabata, S.-I. (2015) · Journal of Biological Chemistry · doi:10.1074/jbc.m115.653196 · Cited by 23
Chemical structure and immunobiological activity of lipid A from Serratia marcescens LPS
Makimura, Y., Asai, Y., Sugiyama, A., & Ogawa, T. (2007) · Journal of Medical Microbiology · doi:10.1099/jmm.0.47327-0 · Cited by 23
Bennett, G. M., Seaver, A., & Calcott, P. H. (1981) · Applied and Environmental Microbiology · doi:10.1128/aem.42.5.843-849.1981 · Cited by 22 · cited 1×
“Additionally, (DR) LPS exhibited a higher sensitivity towards freeze/thaw cycles than wild-type or other less rough LPS types [230].”
BackgroundA Novel Antimicrobial Peptide Derived from the Insect Paederus dermatitis
Memarpoor‐Yazdi, M., Zare‐Zardini, H., & Asoodeh, A. (2012) · International Journal of Peptide Research and Therapeutics · doi:10.1007/s10989-012-9320-1 · Cited by 22
Assay of Endotoxin by LimulusAmebocyte Lysate
Ketchum, P. A., & Novitsky, T. J. (2003) · Humana Press eBooks · doi:10.1385/1-59259-216-3:3 · Cited by 21
A g-Type Lysozyme from Deep-Sea Hydrothermal Vent Shrimp Kills Selectively Gram-Negative Bacteria
Luo, J.-C., Zhang, J., & Sun, L. (2021) · Molecules · doi:10.3390/molecules26247624 · Cited by 21 · cited 2×
“, Escherichia coli and Pseudoalteromonas hodoensis—were lysed already at low concentrations of rLysG1, whereas others—such as different Vibrio strains—were not affected at all [193].”
BackgroundSweet, C. R., Watson, R., Landis, C., & Smith, J. P. (2015) · Marine Drugs · doi:10.3390/md13084701 · Cited by 20 · cited 3×
“Colwellia hornerae 2 5 (3 + 2) 9–14 [56]”
InfluentialThe structure of the lipid A component of Sphaerotilus natans
Masoud, H., Urbanik‐Sypniewska, T., Lindner, B., Weckesser, J., & Mayer, H. (1991) · Archives of Microbiology · doi:10.1007/bf00249110 · Cited by 20 · cited 1×
“Sphaerotilus natans 3 (2 + 1) 6 (3 + 3) 10–14 Agonist [22]”
Structural characterization of Bordetella parapertussis lipid A
Hamidi, A. E., Novikov, A., Karibian, D., Perry, M. B., & Caroff, M. (2008) · Journal of Lipid Research · doi:10.1194/jlr.m800454-jlr200 · Cited by 20 · cited 3×
“Bordetella pertussis 2 5 (3 + 2) 10–14 Agonist [34]”
BackgroundKobayashi, Y., Shiga, T., Shibata, T., Sako, M., Maenaka, K., Koshiba, T., Mizumura, H., Oda, T., & Kawabata, S.-I. (2014) · Journal of Biological Chemistry · doi:10.1074/jbc.m114.586933 · Cited by 19
Aldapa-Vega, G., Moreno‐Eutímio, M. A., Berlanga‐Taylor, A. J., Jiménez‐Uribe, A. P., Nieto-Velázquez, N. G., López‐Ortega, O., Mancilla‐Herrera, I., Cortés-Malagón, E. M., Gunn, J. S., Isibasi, A., et al. (2019) · Molecular Immunology · doi:10.1016/j.molimm.2019.03.003 · Cited by 19 · cited 1×
“Salmonella typhimurium 2 6 (4 + 2) 12–14 Agonist [75]”
Identification of Key Residues That Confer Rhodobacter sphaeroides LPS Activity at Horse TLR4/MD-2
Irvine, K. L., Gangloff, M., Walsh, C. M., Spring, D. R., Gay, N. J., & Bryant, C. E. (2014) · PLoS ONE · doi:10.1371/journal.pone.0098776 · Cited by 18 · cited 3×
“Antagonistic LPS variants do not activate the immune system and can even block LPS-binding sites (e.g., TLR4 receptors), preventing the binding of agonistic LPS variants and inhibiting the downstream inflammatory cascade [127].”
BackgroundLorenzo, F. D., Crisafi, F., Cono, V. L., Yakimov, M. M., Molinaro, A., & Silipo, A. (2020) · Marine Drugs · doi:10.3390/md18120592 · Cited by 18 · cited 1×
“A high intra-species heterogeneity was observed for the recently discovered strain Zunongwangia profunda SM-A87 [42] and different psychrophilic bacteria isolated from Antarctica [39].”
BackgroundLow endotoxin recovery and its impact on endotoxin detection
Cao, Y., Zhang, Y., & Qiu, F. (2021) · Biopolymers · doi:10.1002/bip.23470 · Cited by 18
Sweet, C. R., Alpuche, G., Landis, C., & Sandman, B. (2014) · Marine Drugs · doi:10.3390/md12074126 · Cited by 17 · cited 1×
“Psychromonas marina 2 6 (4 + 2) 12–14 [72]”
Research works printed but not linked: 8
- Kolmos, 2006, Panum’s Studies on “Putrid Poison” 1856, Dan. Med. Bull., 53, 450
- Williams, K.L. (2019). Discovery and Early Development of the Limulus Test, Springer International Publishing.
- Loverock, 2010, A Recombinant Factor C Procedure for the Detection of Gram-Negative Bacterial Endotoxin, United States Pharmacop. Conv.-Pharmacop. Forum, 36, 321
- Dawson, 1993, Endotoxin Standards and CSE Potency, LAL Updat., 11, 1
- Tsuchiya, 2014, Possible Mechanism of Low Endotoxin Recovery, Am. Pharm. Rev., 17, 1
- Meadows, 2018, Aseptic Sampling Best Practices Endotoxin Binding Affinity, Sartorius, SP-4006-e, 1
- Novitsky, 1988, The Problems with Plastics, Lal Update, 6, 1
- (2023, February 12). PubMed Keyword “Endotoxin” 5203 Events, Keyword “Lipopolysaccharide” 7853 Events, Available online: https://pubmed.ncbi.nlm.nih.gov/.
Cited by
PAMPs and DAMPs in Sepsis: A Review of Their Molecular Features and Potential Clinical Implications
Cicchinelli, S., Pignataro, G., Gemma, S., Piccioni, A., Picozzi, D., Ojetti, V., Franceschi, F., & Candelli, M. (2024) · International Journal of Molecular Sciences · doi:10.3390/ijms25020962 · Cited by 155
“Recently, it has been highlighted that LPS may enter the cell via a clathrin-mediated endocytosis of outer membrane vesicles (OMVs), or through the preliminary extracellular binding to the HMGB1 protein, and subsequent conjunction with RAGE [45].”
BackgroundInfluentialLipopolysaccharide delivery systems in innate immunity
Liu, J., Kang, R., & Tang, D. (2024) · Trends in Immunology · doi:10.1016/j.it.2024.02.003 · Cited by 113
Peregrino, E. S., Castañeda‐Casimiro, J., Vázquez-Flores, L., Estrada-Parra, S. A., Baeza, C. W., Serafín‐López, J., & Wong‐Baeza, I. (2024) · International Journal of Molecular Sciences · doi:10.3390/ijms25116210 · Cited by 70
Boronic acid-assisted detection of bacterial pathogens: Applications and perspectives
Gao, S., Zhang, Y., Zhou, R., Shen, T., Zhang, D., Guo, Z., & Zou, X. (2024) · Coordination Chemistry Reviews · doi:10.1016/j.ccr.2024.216082 · Cited by 57
Michelini, S., Mawas, S., Kurešepi, E., Barbero, F., Šimunović, K., Miremont, D., Devineau, S., Schicht, M., Ganin, V. S., Haugen, Ø. P., et al. (2025) · Journal of Nanobiotechnology · doi:10.1186/s12951-025-03419-6 · Cited by 40
“Thus, in this context, the use of this assay is particularly relevant as it more closely reflects the natural response of cells to endotoxins when compared, for example, to a standard limulus amoebocyte lysate assay (LAL) [37, 38].”
Self-citation
Metadata
- Authors
- Fux, A. C., Casonato Melo, C., Michelini, S., Swartzwelter, B. J., Neusch, A., Italiani, P., & Himly, M.
- Affiliations
- Miltenyi Biotec (Germany) (DE)
- Division of Allergy & Immunology, Department of Biosciences & Medical Biology, Paris Lodron University of Salzburg (PLUS), Hellbrunnerstraße 34, 5020 Salzburg, Austria
- University of Ljubljana (SI)
- Colorado State University (US)
- Heinrich Heine University Düsseldorf (DE)
- Stazione Zoologica Anton Dohrn (IT)
- University of Salzburg (AT)
- Corresponding author
- Himly, Martin
- ORCID
- Venue
- International Journal of Molecular Sciences
- Publisher
- MDPI AG
- Published
- 2023-05-07
- Volume
- 24
- Issue
- 9
- Pages
- 8395
- ISSN
- 1422-0067 (ISSN-L)
- PMC
- PMC10179214
- OpenAlex
- W4375862682
- Cited by
- 83
- References
- 225
- Citations by year
- 2026: 27 · 2025: 24 · 2024: 26 · 2023: 6
- FWCI
- 2.30
- Type
- journal article
- Language
- en
- Open access
- gold
- doi.org
- Licence
- Locations
- International Journal of Molecular Sciences (publishedVersion, cc-by)
- PubMed Central (publishedVersion, cc-by)
- PubMed (publishedVersion)
- Repository of the University of Ljubljana (University of Ljubljana) (submittedVersion, cc-by)
- Funders
- European Union’s Horizon 2020 research and innovation programme (H2020-MSCA-ITN-2018-812661, 890610)
- Austrian Research Promotion Agency (FFG) (H2020-MSCA-ITN-2018-812661, 890610)
- Topics
- Life Sciences › Immunology and Microbiology › Immunology › Immune Response and Inflammation
- Life Sciences › Immunology and Microbiology › Microbiology › Escherichia coli research studies
- Health Sciences › Medicine › Critical Care and Intensive Care Medicine › Sepsis Diagnosis and Treatment
- Keywords
- lipopolysaccharide, endotoxin, LPS-binding protein, Gram-negative bacteria, pathogen-associated molecular patterns, septic shock
- MeSH terms
- Biological Assay, Endotoxins, Humans, Lipopolysaccharides, Shock, Septic, Signal Transduction
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.